| Financial Year |
March 31 2023 |
| Monetary Funds |
1,595,710,869.52 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
10,832,029.86 |
| Accounts Receivable |
537,827,171.76 |
| Advances to Suppliers |
429,672.17 |
| Other Receivables |
2,436,624.55 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
-- |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
7,368,845.93 |
| Total Current Assets |
2,154,605,213.79 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
6,373,426.21 |
| Investment Properties |
147,672,944.46 |
| Fixed Assetes |
572,378,542.85 |
| Under-construction Projects |
895,466.13 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,028,666.89 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
3,890,254.82 |
| Deferred Income Tax Assets |
39,447,116.98 |
| Other Non-Current Assets |
288,565,210.94 |
| Sub-Total of Non-Current Assets |
1,093,050,984.11 |
| Total Assets |
3,247,656,197.90 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
32,517,176.72 |
| Accounts Received In Advance |
16,462.81 |
| Employee Compensation Payable |
13,873,319.39 |
| Taxes Payable |
14,302,362.57 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,741,966.12 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
7,828,307.80 |
| Other Current Liabilities |
3,399,314.83 |
| Sub-Total of Current Liabilities |
130,419,062.32 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
30,734,114.39 |
| Total Liabilities |
161,153,176.71 |
| Paid-In Capital(Or Share Stock) |
128,000,000.00 |
| Capital Surplus |
2,351,815,535.46 |
| Surplus Reserve |
48,623,741.01 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
555,884,156.84 |
| Minority Stockholder's Interest |
2,179,587.88 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,084,323,433.31 |
| Owner's Equity（Stockholder's Equity） |
3,086,503,021.19 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,247,656,197.90 |
